Recent 8-K filings for TKNO

• May 06, 2026 23:59 UTC earnings materiality 0.70 positive item 2.02item 9.01item 5.05

  Teknova Q1 revenue $11.1M (+13% YoY); reaffirms FY 2026 guidance $42-44M

  Total revenue $11.1M, up 13% YoY; Clinical Solutions revenue surged 85% to $2.1M.

• Feb 26, 2026 23:59 UTC earnings materiality 0.80 neutral item 2.02item 9.01

  Alpha Teknova reports Q4 and FY2025 revenue growth, provides 2026 guidance of $42-44M

  Full year 2025 total revenue $40.5M, up 7% from $37.7M in 2024.

• Nov 06, 2025 23:59 UTC earnings materiality 0.60 positive item 2.02item 9.01

  Teknova Q3 revenue $10.5M (+9% YoY); net loss narrows to $4.3M; reaffirms FY2025 guidance

  Revenue $10.5M, up 9% from Q3 2024; Lab Essentials $8.3M (+16%), Clinical Solutions $1.7M (-13%).

• Aug 07, 2025 23:59 UTC earnings materiality 0.65 positive item 2.02item 9.01

  Teknova Q2 revenue $10.3M (+7% YoY); net loss narrows to $3.6M; reaffirms FY25 guidance $39-42M

  Q2 2025 revenue of $10.3M, up 7% from $9.6M in Q2 2024.

• May 08, 2025 23:59 UTC earnings materiality 0.60 neutral item 2.02item 9.01

  Teknova Q1 revenue up 5% to $9.8M, net loss narrows to $4.6M, guidance reaffirmed

  Q1 total revenue $9.8M (+5% YoY); Lab Essentials $8.1M (+12%), Clinical Solutions $1.2M (-32%).

• Mar 04, 2025 23:59 UTC earnings materiality 0.75 positive item 1.01item 2.02item 9.01

  Teknova reports FY2024 revenue $37.7M (+3% YoY), guides FY2025 $39-42M, amends credit facility

  FY2024 revenue $37.7M (+3% YoY); Q4 revenue $9.3M (+18% YoY). Clinical Solutions Q4 revenue $1.85M (+110% YoY).

Earnings & guidance

Materiality & sentiment trend

Max materiality 0.80 · Median 0.65 · Most common event earnings

4 positive 0 negative 3 neutral

source · TKNO on sec.gov